» Articles » PMID: 23615903

The A128T Resistance Mutation Reveals Aberrant Protein Multimerization As the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2013 Apr 26
PMID 23615903
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Allosteric HIV-1 integrase (IN) inhibitors (ALLINIs) are a very promising new class of anti-HIV-1 agents that exhibit a multimodal mechanism of action by allosterically modulating IN multimerization and interfering with IN-lens epithelium-derived growth factor (LEDGF)/p75 binding. Selection of viral strains under ALLINI pressure has revealed an A128T substitution in HIV-1 IN as a primary mechanism of resistance. Here, we elucidated the structural and mechanistic basis for this resistance. The A128T substitution did not affect the hydrogen bonding between ALLINI and IN that mimics the IN-LEDGF/p75 interaction but instead altered the positioning of the inhibitor at the IN dimer interface. Consequently, the A128T substitution had only a minor effect on the ALLINI IC50 values for IN-LEDGF/p75 binding. Instead, ALLINIs markedly altered the multimerization of IN by promoting aberrant higher order WT (but not A128T) IN oligomers. Accordingly, WT IN catalytic activities and HIV-1 replication were potently inhibited by ALLINIs, whereas the A128T substitution in IN resulted in significant resistance to the inhibitors both in vitro and in cell culture assays. The differential multimerization of WT and A128T INs induced by ALLINIs correlated with the differences in infectivity of HIV-1 progeny virions. We conclude that ALLINIs primarily target IN multimerization rather than IN-LEDGF/p75 binding. Our findings provide the structural foundations for developing improved ALLINIs with increased potency and decreased potential to select for drug resistance.

Citing Articles

The primary mechanism for highly potent inhibition of HIV-1 maturation by lenacapavir.

Huang S, Briganti L, Annamalai A, Greenwood J, Shkriabai N, Haney R PLoS Pathog. 2025; 21(1):e1012862.

PMID: 39869652 PMC: 11892807. DOI: 10.1371/journal.ppat.1012862.


The structural and mechanistic bases for the viral resistance to allosteric HIV-1 integrase inhibitor pirmitegravir.

Dinh T, Tber Z, Rey J, Mengshetti S, Annamalai A, Haney R mBio. 2024; 15(11):e0046524.

PMID: 39404354 PMC: 11559089. DOI: 10.1128/mbio.00465-24.


Optimizing the Multimerization Properties of Quinoline-Based Allosteric HIV-1 Integrase Inhibitors.

Sun J, Kessl J Viruses. 2024; 16(2).

PMID: 38399977 PMC: 10892445. DOI: 10.3390/v16020200.


The structural and mechanistic bases for the viral resistance to allosteric HIV-1 integrase inhibitor pirmitegravir.

Dinh T, Tber Z, Rey J, Mengshetti S, Annamalai A, Haney R bioRxiv. 2024; .

PMID: 38328097 PMC: 10849636. DOI: 10.1101/2024.01.26.577387.


Dihydroxyphenyl- and Heteroaromatic-Based Thienopyrimidinones to Tackle HIV-1 LEDGF/p75-Dependent IN Activity.

Tocco G, Canton S, Laus A, Caboni P, Le Grice S, Tramontano E Molecules. 2023; 28(18).

PMID: 37764476 PMC: 10537185. DOI: 10.3390/molecules28186700.


References
1.
Maertens G, Cherepanov P, Pluymers W, Busschots K, De Clercq E, Debyser Z . LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem. 2003; 278(35):33528-39. DOI: 10.1074/jbc.M303594200. View

2.
Tsiang M, Jones G, Niedziela-Majka A, Kan E, Lansdon E, Huang W . New class of HIV-1 integrase (IN) inhibitors with a dual mode of action. J Biol Chem. 2012; 287(25):21189-203. PMC: 3375541. DOI: 10.1074/jbc.M112.347534. View

3.
McKee C, Kessl J, Shkriabai N, Dar M, Engelman A, Kvaratskhelia M . Dynamic modulation of HIV-1 integrase structure and function by cellular lens epithelium-derived growth factor (LEDGF) protein. J Biol Chem. 2008; 283(46):31802-12. PMC: 2581560. DOI: 10.1074/jbc.M805843200. View

4.
Christ F, Shaw S, Demeulemeester J, Desimmie B, Marchand A, Butler S . Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization. Antimicrob Agents Chemother. 2012; 56(8):4365-74. PMC: 3421592. DOI: 10.1128/AAC.00717-12. View

5.
Cherepanov P, Ambrosio A, Rahman S, Ellenberger T, Engelman A . Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc Natl Acad Sci U S A. 2005; 102(48):17308-13. PMC: 1297672. DOI: 10.1073/pnas.0506924102. View